iSpecimen Inc. (ISPC) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $152.00; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $87.72M; Treasury Stock, ValueUSD $172.00.
- 2026-03-31: Common Stock, Value, IssuedUSD $2.97K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $85.44M; Treasury Stock, ValueUSD $172.00.
- 2025-12-31: Common Stock, Value, IssuedUSD $21.00; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $85.44M; Treasury Stock, ValueUSD $172.00.
- 2025-09-30: Common Stock, Value, IssuedUSD $977.00; Additional Paid in Capital, Common StockUSD $80.42M; Additional Paid in CapitalUSD (m); Treasury Stock, ValueUSD $172.00.
iSpecimen Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $152.00 | (m) | $87.72M | $172.00 | (m) | $-85.99M | $1.74M | 39.00 | (m) | 3 month · $153.00 | (m) | (m) | (m) |
| 2026-03-31 | $2.97K | (m) | $85.44M | $172.00 | (m) | $-84.63M | $814.04K | 1.55K | (m) | 3 month · $153.00 | (m) | (m) | (m) |
| 2025-12-31 | $21.00 | (m) | $85.44M | $172.00 | (m) | $-82.35M | $3.09M | 39.00 | (m) | 12 month · $1.34K | (m) | (m) | (m) |
| 2025-09-30 | $977.00 | $80.42M | (m) | $172.00 | (m) | $-77.35M | $3.07M | 1.55K | (m) | 3 month · $94.00 | (m) | (m) | (m) |
| 2025-06-30 | $250.00 | $75.19M | (m) | $172.00 | (m) | $-74.57M | $621.97K | 1.55K | 3 month · $1.10K | 3 month · $-66.00 | (m) | 3 month · $1.10K | (m) |
| 2025-03-31 | $250.00 | $75.19M | (m) | $172.00 | (m) | $-73.52M | $1.67M | 1.55K | (m) | 3 month · $1.16K | 3 month · $1.16K | (m) | (m) |
| 2024-12-31 | $170.00 | $75.17M | $75.17M | $172.00 | (m) | $-71.86M | $3.31M | 1.55K | (m) | 12 month · $101.84K | 12 month · $101.84K | 12 month · $366.19K | (m) |
| 2024-09-30 | $83.00 | (m) | $70.53M | $172.00 | (m) | $-65.82M | $4.71M | 1.55K | (m) | 3 month · $20.30K | 3 month · $20.30K | (m) | (m) |
| 2024-06-30 | $1.31K | (m) | $70.46M | $172.00 | (m) | $-64.38M | $6.09M | 1.55K | 3 month · $50.44K | 3 month · $34.83K | 3 month · $34.83K | (m) | (m) |
| 2024-03-31 | $947.00 | (m) | $69.08M | $172.00 | $41.00 | $-62.27M | $6.81M | 1.55K | 3 month · $204.84K | 3 month · $45.87K | 3 month · $45.87K | 3 month · $52.50K | (m) |
| 2023-12-31 | $45.00 | (m) | $69.11M | $172.00 | $840.00 | $-59.36M | $9.74M | 1.55K | (m) | (m) | 12 month · $160.01K | (m) | (m) |
| 2023-09-30 | $907.00 | (m) | $69.00M | $172.00 | $641.00 | $-56.29M | $12.71M | 1.55K | (m) | (m) | 3 month · $49.39K | (m) | (m) |
| 2023-06-30 | $906.00 | (m) | $68.89M | $172.00 | $688.00 | $-54.18M | $14.71M | 31.00K | (m) | (m) | 3 month · $29.83K | (m) | (m) |
| 2023-03-31 | $902.00 | (m) | $68.76M | $172.00 | $18.84K | $-50.70M | $18.08M | 31.00K | (m) | (m) | 3 month · $54.61K | (m) | 31.00K |
| 2022-12-31 | $892.00 | (m) | $68.57M | $172.00 | (m) | $-48.27M | $20.31M | 1.55K | (m) | (m) | 12 month · $642.08K | (m) | 31.00K |
| 2022-09-30 | $888.00 | (m) | $68.53M | $172.00 | (m) | $-46.11M | $22.42M | (m) | (m) | (m) | 3 month · $183.27K | (m) | 31.00K |
| 2022-06-30 | $887.00 | (m) | $68.31M | $172.00 | (m) | $-43.01M | $25.30M | (m) | (m) | (m) | 3 month · $202.32K | (m) | 31.00K |
| 2022-03-31 | $881.00 | (m) | $68.07M | $172.00 | (m) | $-40.40M | $27.67M | (m) | (m) | (m) | 3 month · $183.41K | (m) | 31.00K |
| 2021-12-31 | $873.00 | (m) | $67.81M | $172.00 | (m) | $-38.02M | $29.79M | 31.00K | 12 month · $2.34M | (m) | 12 month · $622.06K | 12 month · $49.07K | 31.00K |
| 2021-09-30 | $697.00 | (m) | $48.06M | $172.00 | (m) | $-35.97M | $12.09M | (m) | (m) | (m) | 3 month · $399.82K | 3 month · $49.07K | 31.00K |
| 2021-06-30 | $657.00 | (m) | $45.09M | $172.00 | (m) | $-34.42M | $10.68M | (m) | 3 month · $2.34M | (m) | 3 month · $28.37K | (m) | 31.00K |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-31.22M | (m) | (m) | (m) | 3 month · $22.04K | (m) | (m) |
| 2020-12-31 | $94.00 | (m) | $1.78M | $172.00 | (m) | $-29.06M | $-27.28M | (m) | (m) | (m) | 12 month · $92.87K | (m) | 31.00K |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $-25.70M | (m) | (m) | (m) | 3 month · $29.27K | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | $-24.48M | (m) | (m) | (m) | 3 month · $29.29K | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-24.33M | (m) | (m) | (m) | 3 month · $22.05K | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-22.72M | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |